These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10773331)

  • 1. Leakage of enteric (Eudragit L)-coated dosage forms in simulated gastric juice in the presence of poly(ethylene glycol).
    Breitkreutz J
    J Control Release; 2000 Jun; 67(1):79-88. PubMed ID: 10773331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
    Chen MM; Wang CR; Jin Y
    Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth)acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil.
    Satturwar P; Eddine MN; Ravenelle F; Leroux JC
    Eur J Pharm Biopharm; 2007 Mar; 65(3):379-87. PubMed ID: 17123802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rocket-like encapsulation and delivery system with two-stage booster layers: pH-responsive poly(methacrylic acid)/poly(ethylene glycol) complex-coated hollow silica vesicles.
    Lay CL; Kumar JN; Liu CK; Lu X; Liu Y
    Macromol Rapid Commun; 2013 Oct; 34(19):1563-8. PubMed ID: 23996916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
    Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
    Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of polyethylene glycol (PEG) to the control of permeability of poly(meth)acrylate coatings].
    Hennig D; Kala H
    Pharmazie; 1987 Jan; 42(1):26-8. PubMed ID: 3575399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Mucoadhesive Interactions Between Porcine Gastric Mucin and Some Water-Soluble Polymers.
    Albarkah YA; Green RJ; Khutoryanskiy VV
    Macromol Biosci; 2015 Nov; 15(11):1546-53. PubMed ID: 26102520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility.
    Alhnan MA; Cosi D; Murdan S; Basit AW
    J Pharm Sci; 2010 Nov; 99(11):4576-83. PubMed ID: 20845456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and release studies of a cationic drug from a star-shaped four-arm poly(ethylene oxide)-b-poly(methacrylic acid).
    He E; Yue CY; Tam KC
    J Pharm Sci; 2010 Feb; 99(2):782-93. PubMed ID: 19653271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of sensor elements to control drug release from capsular drug delivery systems.
    Gröning R; Danco I; Müller RS
    Int J Pharm; 2007 Aug; 340(1-2):61-4. PubMed ID: 17462841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.
    Wulff R; Leopold CS
    AAPS PharmSciTech; 2016 Apr; 17(2):493-503. PubMed ID: 26265188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel use of Eudragit NE 30D/Eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications.
    El-Malah Y; Nazzal S
    Int J Pharm; 2008 Jun; 357(1-2):219-27. PubMed ID: 18353571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical model for enteric film coating of tablets.
    Dinçer S; Ozdurmuş S
    J Pharm Sci; 1977 Aug; 66(8):1070-3. PubMed ID: 894491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms.
    Siepmann F; Hoffmann A; Leclercq B; Carlin B; Siepmann J
    J Control Release; 2007 Jun; 119(2):182-9. PubMed ID: 17391796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.